{
    "eid": "2-s2.0-84995704440",
    "title": "Global comparison of drug resistance mutations after first-line antiretroviral therapy across human immunodeficiency virus-1 subtypes",
    "cover-date": "2016-04-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        }
    ],
    "keywords": [
        "Drug resistance",
        "Evolution",
        "First-line",
        "HIV",
        "Subtype"
    ],
    "authors": [
        "Austin Huang"
    ],
    "citedby-count": 14,
    "ref-count": 39,
    "ref-list": [
        "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection",
        "Consolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach",
        "Response to the AIDS pandemic - A global health model",
        "The challenge of HIV-1 subtype diversity",
        "HIV-1 nomenclature proposal [3]",
        "Global trends in molecular epidemiology of HIV-1 during 2000-2007",
        "Replicative capacity differences of thymidine analog resistance mutations in subtype B and C human immunodeficiency virus type 1",
        "Replicative fitness costs of nonnucleoside reverse transcriptase inhibitor drug resistance mutations on HIV subtype C",
        "Differential In Vitro Kinetics of Drug Resistance Mutation Acquisition in HIV-1 RT of Subtypes B and C",
        "Impact of HIV type 1 subtype on drug resistance mutations in Nigerian patients failing first-line therapy",
        "Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa",
        "Two subtypes of HIV-1 among injection-drug users in southern China",
        "The HIV-1 subtype C epidemic in South America is linked to the United Kingdom",
        "HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture",
        "The K65R mutation in HIV-1 reverse transcriptase: Genetic barriers, resistance profile and clinical implications",
        "Synonymous genetic polymorphisms within Brazilian human immunodefidency virus type 1 subtypes may influence mutational routes to drug resistance",
        "Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration",
        "Global analysis of sequence diversity within HIV-1 subtypes across geographic regions",
        "Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir",
        "Characterization of HIV type 1 subtype C protease gene: Selection of L63P mutation in protease inhibitor-naive Indian patients",
        "Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis",
        "Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-saharan african countries: Implications for second-line ART strategies",
        "Impact of HIV-1 pol diversity on drug resistance and its clinical implications",
        "HIV treatment as prevention",
        "Patients infected with HIV type 1 subtype CRF01-AE and failing first-line nevirapine- and efavirenz-based regimens demonstrate considerable cross-resistance to etravirine",
        "The impact of HIV drug resistance on the selection of first- and second-line ART in resource-limited settings",
        "Human immunodeficiency virus reverse transcriptase and protease sequence database",
        "Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase",
        "Rapid Advice: Antiretroviral Therapy for HIV Infection in Adults and Adolescents",
        "Update of the drug resistance mutations in HIV-1: March 2013",
        "A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors",
        "The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in Southern Africa",
        "Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine",
        "The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions",
        "Subtype-specific differences in the human immunodeficiency virus type 1 reverse transcriptase connection subdomain of CRF01-AE are associated with higher levels of resistance to 3\u2032-azido-3\u2032-deoxythymidine",
        "Impact of CRF01_AE-specific polymorphic mutations G335D and A371V in the connection subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on susceptibility to nucleoside RT inhibitors",
        "Why do HIV-1 subtypes segregate among persons with different risk behaviors in South Africa and Thailand?",
        "Replicating genotype-phenotype associations",
        "Why We (Usually) Don't Have to Worry About Multiple Comparisons"
    ],
    "affiliation": [
        {
            "affiliation-city": "Beijing",
            "affilname": "Beijing Ditan Hospital Capital Medical University",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Eldoret",
            "affilname": "Moi University",
            "affiliation-country": "Kenya"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Stanford",
            "affilname": "Stanford University",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Providence",
            "affilname": "Brown University",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Providence",
            "affilname": "The Warren Alpert Medical School",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chennai",
            "affilname": "YRG CARE",
            "affiliation-country": "India"
        }
    ],
    "funding": [
        "National Institutes of Health"
    ]
}